Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Life Medical Sciences (CHAI) for Hair Regrowth? -- Ignore unavailable to you. Want to Upgrade?

To: Art Odell who wrote (1149)	1/11/2001 7:44:01 PM
From: Gregory Messenger	Respond to of 1152

Ditto Art. Very important to me as well. It is amazing that we were at 4 cents less than a month ago. If nothing else, we've earned this one! I agree with your assessment. Clearly there will be some more dilution but the alternative was death. The new boys are not going to let their money go down the drain and they have two voices on the board. In addition, they're in the heart field! Looking good. Art, I am going to laugh so long and so hard if this baby finally pays off. I've written these guys off several times.

To: Art Odell who wrote (1149)	1/20/2001 8:23:01 PM
From: Gregory Messenger	Respond to of 1152

Correction Art, I said they were in the heart field, they're not. The press release was certainly clear enough, I guess my enthusiasm clouded my vision. As I re read the press release I gain confidence. Dr. diZerega of USC is an OBGyn "world renowned expert and medical industry consultant in the field of post-operative adhesions". Well, clearly he's seen the Repel CV results to date and he likes what he's seen and what he has heard about the OBGyn applications, which come after Repel CV is a success. All of a sudden my vision is crystal clear. We have a world renowned cardiovascular surgeon in Dr. Oz. We now have a world renowned post-op adhesion expert who happens to be an OBGyn doc, Repels next breakthrough, after CV. Clearly these guys believe that this product works. I really have to believe that Dr. diZerega and Dr. Franklin have to feel like foxes in a hen house. 5,000,000 shares at 0.10 for a breakthrough product that ultimately has breakthrough applications. Art, I've recently been reflecting on the importance that this product can have for mankind. To this point I've spent most of my time thinking about how it can make me comfortably retired. It's just now deeply sinking in what this can mean for all of us. Can you imagine how satisfied we will feel about this investment after this product hits the market? It's one thing to get wealthy investing in technology, it's a whole different thing to get wealthy investing in a breakthrough medicine that benefits mankind. I really think this is going to happen. I am going to be happy that we benefit financially but I'm going to be very proud that we were involved in this medical breakthrough.